IL80971A - Peptides with sulfate ester groups,their preparation and pharmaceutical compositions containing them - Google Patents
Peptides with sulfate ester groups,their preparation and pharmaceutical compositions containing themInfo
- Publication number
- IL80971A IL80971A IL80971A IL8097186A IL80971A IL 80971 A IL80971 A IL 80971A IL 80971 A IL80971 A IL 80971A IL 8097186 A IL8097186 A IL 8097186A IL 80971 A IL80971 A IL 80971A
- Authority
- IL
- Israel
- Prior art keywords
- peptides
- ester groups
- sulfate ester
- preparation
- pharmaceutical compositions
- Prior art date
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 230000008602 contraction Effects 0.000 abstract 1
- 210000000232 gallbladder Anatomy 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/595—Gastrins; Cholecystokinins [CCK]
- C07K14/5955—Gastrins; Cholecystokinins [CCK] at least 1 amino acid in D-form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Endocrinology (AREA)
- Genetics & Genomics (AREA)
- Hematology (AREA)
- Child & Adolescent Psychology (AREA)
- Obesity (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US81094885A | 1985-12-19 | 1985-12-19 | |
| US93211986A | 1986-11-18 | 1986-11-18 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL80971A0 IL80971A0 (en) | 1987-03-31 |
| IL80971A true IL80971A (en) | 1991-12-12 |
Family
ID=27123406
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL80971A IL80971A (en) | 1985-12-19 | 1986-12-15 | Peptides with sulfate ester groups,their preparation and pharmaceutical compositions containing them |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0226217B1 (de) |
| JP (1) | JP2569316B2 (de) |
| AT (1) | ATE100821T1 (de) |
| AU (1) | AU596388B2 (de) |
| DE (2) | DE226217T1 (de) |
| DK (1) | DK608186A (de) |
| ES (1) | ES2000108T3 (de) |
| FI (1) | FI86193C (de) |
| IE (1) | IE62659B1 (de) |
| IL (1) | IL80971A (de) |
| NO (1) | NO865132L (de) |
| NZ (1) | NZ218607A (de) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5086042A (en) * | 1985-12-19 | 1992-02-04 | Fisons Corporation | Peptides with sulfate ester groups |
| US4808701A (en) * | 1987-03-30 | 1989-02-28 | Hoffmann-La Roche Inc. | Cyclic peptides having appetite regulating activity |
| ZA878594B (en) * | 1987-05-27 | 1989-07-26 | Pennwalt Corp | Peptides with sulfate ester groups |
| ZA883929B (en) * | 1987-06-22 | 1990-02-28 | Hoffmann La Roche | Cholecystokinin analogs for controlling appetite |
| US5182263A (en) * | 1988-04-25 | 1993-01-26 | Hoffmann-La Roche Inc. | Analogs of tyrosine sulfate or tyrosine phosphate containing peptides |
| JPH0219396A (ja) * | 1988-07-06 | 1990-01-23 | Shionogi & Co Ltd | 新規ペプチドおよびそれを含有する脳機能改善剤 |
| FR2634763B1 (fr) * | 1988-08-01 | 1991-07-12 | Inst Nat Sante Rech Med | Amino-acides et peptides presentant un residu tyrosine modifiee, leur preparation et leur application comme medicaments |
| US5631230A (en) * | 1989-09-21 | 1997-05-20 | Arizona Technology Development Corporation | Receptor selective analogues of cholecystokinin-8 |
| JPH05500962A (ja) * | 1989-11-27 | 1993-02-25 | アストラ・アクチエボラーグ | 硫酸エステル基を有するヘキサペプチド |
| US5502164A (en) * | 1989-11-27 | 1996-03-26 | Fisons Corporation | Peptide compounds having therapeutic activity |
| CA2106765A1 (en) * | 1991-04-24 | 1992-11-12 | David C. Horwell | Cck analogs containing ó-substituted amino acids |
| MX9207458A (es) * | 1991-12-20 | 1993-11-01 | Fisons Corp | Compuestos de peptido que tienen actividad terapeutica. |
| EP1663282A4 (de) * | 2003-09-24 | 2007-09-19 | Vecta Ltd | Orale zusammensetzungen zur stimulierung der magensäuresekretion mit pentagastrin |
| CN103833593B (zh) * | 2014-03-21 | 2016-08-17 | 四川什邡市三高生化实业有限公司 | 一种n-(9-芴甲氧羰基)-o-叔丁基-l-酪氨酸的制备方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4842633A (de) * | 1971-09-30 | 1973-06-21 | ||
| JPS5130069A (ja) * | 1974-09-05 | 1976-03-13 | Nogyo Kikaika Kenkyusho | Kokumotsushuyobukuro |
| DD128973B1 (de) * | 1976-11-29 | 1979-11-28 | Hartmut Niedrich | Verfahren zur herstellung von peptiden,die tyrosinsulfat enthalten |
| US4351829A (en) * | 1980-09-26 | 1982-09-28 | Farmitalia Carlo Erba Spa | Use of polypeptides as analgesic drugs |
| JPS57146745A (en) * | 1981-03-09 | 1982-09-10 | Amano Pharmaceut Co Ltd | Peptide amidosulfate ester derivative and its preparation |
| DK489683A (da) * | 1982-10-27 | 1984-04-28 | Amano Pharma Co Ltd | Fremgangsmaade til fremstilling af peptider |
| JPS5978151A (ja) * | 1982-10-27 | 1984-05-04 | Amano Pharmaceut Co Ltd | 新規ペプチド及びこれを含有する抗精神分裂病薬剤 |
| JPS6028992A (ja) * | 1983-07-20 | 1985-02-14 | Amano Pharmaceut Co Ltd | ペプチド及びこれを含有する抗精神分裂病薬剤 |
| US4490364A (en) * | 1983-05-20 | 1984-12-25 | The Salk Institute For Biological Studies | CCK Agonists II |
| JPS60100595A (ja) * | 1983-11-04 | 1985-06-04 | Amano Pharmaceut Co Ltd | 新規ペプチド |
| JPS60194000A (ja) * | 1984-03-14 | 1985-10-02 | Amano Pharmaceut Co Ltd | ペプチドアミドスルフエ−トエステル |
| EP0161468A3 (de) * | 1984-05-07 | 1988-10-26 | Pennwalt Corporation | Festphasen-Peptidsynthese welche sulfatiertes Tyrosin enthält |
| JPS62126198A (ja) * | 1985-11-26 | 1987-06-08 | Amano Pharmaceut Co Ltd | ペプチドアミドスルフエ−トエステル |
-
1986
- 1986-12-11 NZ NZ218607A patent/NZ218607A/xx unknown
- 1986-12-15 IL IL80971A patent/IL80971A/xx not_active IP Right Cessation
- 1986-12-17 DK DK608186A patent/DK608186A/da not_active Application Discontinuation
- 1986-12-17 DE DE198686117612T patent/DE226217T1/de active Pending
- 1986-12-17 FI FI865163A patent/FI86193C/fi not_active IP Right Cessation
- 1986-12-17 EP EP86117612A patent/EP0226217B1/de not_active Expired - Lifetime
- 1986-12-17 IE IE330086A patent/IE62659B1/en not_active IP Right Cessation
- 1986-12-17 DE DE3689585T patent/DE3689585T2/de not_active Expired - Fee Related
- 1986-12-17 NO NO865132A patent/NO865132L/no unknown
- 1986-12-17 ES ES86117612T patent/ES2000108T3/es not_active Expired - Lifetime
- 1986-12-17 AT AT86117612T patent/ATE100821T1/de not_active IP Right Cessation
- 1986-12-18 JP JP61300198A patent/JP2569316B2/ja not_active Expired - Lifetime
- 1986-12-18 AU AU66714/86A patent/AU596388B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| IL80971A0 (en) | 1987-03-31 |
| NZ218607A (en) | 1989-10-27 |
| ES2000108T3 (es) | 1994-12-16 |
| ES2000108A4 (es) | 1987-12-01 |
| FI865163L (fi) | 1987-06-20 |
| NO865132D0 (no) | 1986-12-17 |
| EP0226217B1 (de) | 1994-01-26 |
| FI865163A0 (fi) | 1986-12-17 |
| JP2569316B2 (ja) | 1997-01-08 |
| DE226217T1 (de) | 1988-01-14 |
| NO865132L (no) | 1987-06-22 |
| DK608186A (da) | 1987-08-20 |
| ATE100821T1 (de) | 1994-02-15 |
| AU596388B2 (en) | 1990-05-03 |
| DK608186D0 (da) | 1986-12-17 |
| DE3689585D1 (de) | 1994-03-10 |
| EP0226217A3 (en) | 1989-05-24 |
| EP0226217A2 (de) | 1987-06-24 |
| AU6671486A (en) | 1987-06-25 |
| IE863300L (en) | 1987-06-19 |
| FI86193B (fi) | 1992-04-15 |
| JPS62228100A (ja) | 1987-10-06 |
| IE62659B1 (en) | 1995-02-22 |
| FI86193C (fi) | 1992-07-27 |
| DE3689585T2 (de) | 1994-07-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU596388B2 (en) | Peptides with sulfate ester groups | |
| MX163955B (es) | Composicion farmaceutica de dihidrocodeina e ibuprofen | |
| CA2120303A1 (en) | Cyclic adhesion inhibitors | |
| NO852872L (no) | Fremgangsmaate for fremstilling av nye tetrapyrroler. | |
| GEP20002300B (en) | Purified Forms of Dnase, Method for Its Production, Pharmaceutical Composition and Use Thereof | |
| EP0203649A3 (en) | Pharmaceutic composition based on diphoshonates for the treatment of the arthrosis | |
| DE3588095D1 (de) | Polypeptid, dessen Verfahren zur Herstellung und dieses enthaltende pharmazeutische Zusammensetzung und deren Benutzung | |
| MY109309A (en) | Improvements in or relating to somatostatins | |
| GB9221414D0 (en) | Pharmaceutical compositions | |
| NZ227944A (en) | Synergistic pharmaceutical composition of a hybrid interferon and a muramylpeptide | |
| IE873084L (en) | Peptides with sulfate ester groups | |
| IE882610L (en) | Novel calcium supplements | |
| HUT55034A (en) | Process for producing peptides with hemoregulating effect and pharmaceutical compositions comprising such compounds as active ingredient | |
| DE69414857D1 (de) | Präparat gegen haarausfall und brüchiche nägel | |
| EP0288758A3 (en) | Dihydropyridinamides, process for their preparation and their use in medicines | |
| GR3017321T3 (en) | Use of amino acids for the protection of and metabolic recovery of ischemic cardiac tissue. | |
| IL84551A0 (en) | Peptides,their preparation and pharmaceutical compositions containing them | |
| IL85776A (en) | Pharmaceutical compositions comprising certain selenium containing algae and c18-c22 unsaturated acids and their preparation,used for treating conditions of the heart and cardiovascular system | |
| EP0613375A4 (de) | Pharmazeutische lysin enthaltende polypeptid-zusammensetzungen und verfahren zu deren verwendung. | |
| IE831399L (en) | Pharmaceutical composition containing meptazinol and¹ibuprofen. | |
| EP0382180A3 (en) | Derivatives of thiazolidine-4-carboxylic acid, its preparation and pharmaceutical compositions containing it | |
| GB2260702B (en) | Improvements relating to the treatment of haemophilia B by subcutaneous injection of factor 1X | |
| HU896326D0 (en) | Process for the preparation of aminoacid derivatives and pharmaceutical compositions thereof | |
| ES8204713A1 (es) | Un procedimiento para aislar un polipeptido purificado | |
| EP0342015A3 (de) | Peptide, deren Benutzung und sie enthaltende pharmazeutische Zusammensetzungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RH | Patent void |